blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1909770

EP1909770 - ORAL CONTROLLED RELEASE COMPOSITION CONTAINING LEVETIRACETAM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.01.2014
Database last updated on 07.10.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR
published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Sun Pharma Advanced Research Company Ltd
17/B Mahal Industrial Estate OFF, Mahakali Caves Road Andheri (East)
Mumbai 400 093 / IN
[2013/20]
Former [2008/16]For all designated states
Sun Pharmaceutical Industries Limited
Acme Plaza Andheri Kurla Road Andheri (East)
Mumbai 400 059 / IN
Inventor(s)01 / ZALA, Yashoraj, Rupsinh
17/B Mahal Ind. Estate
Off Mahakali Caves Road
Andheri (East), Mumbai 400093 / IN
02 / DHARMADHIKARI, Nitin Bhalachandra
17/B, Mahal Ind. Estate
Off Makali Caves Road
Andheri (East), Mumbai 400093 / IN
 [2013/12]
Former [2008/16]01 / ZALA, Yashoraj, Rupsinh
17/B Mahal Ind. Estate, Off Mahakali Caves Road
Andheri (East), Mumbai 400093 / IN
02 / DHARMADHIKARI, Nitin Bhalachandra
17/B, Mahal Ind. Estate, Off Makali Caves Road
Andheri (East), Mumbai 400093 / IN
Representative(s)HGF
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2013/12]Harrison Goddard Foote
Belgrave Hall
Belgrave Street
Leeds
LS2 8DD / GB
Former [2008/28]Harrison Goddard Foote
Belgrave Hall Belgrave Street Leeds
LS2 8DD / GB
Former [2008/16]Harrison Goddard Foote
Belgrave Hall Belgrave Street
Leeds, LS2 8DD / GB
Application number, filing date06780511.922.02.2006
[2008/16]
WO2006IN00059
Priority number, dateIN2005MUM019622.02.2005         Original published format: IN MU01962005
[2008/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006123357
Date:23.11.2006
Language:EN
[2006/47]
Type: A2 Application without search report 
No.:EP1909770
Date:16.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 23.11.2006 takes the place of the publication of the European patent application.
[2008/16]
Type: B1 Patent specification 
No.:EP1909770
Date:20.03.2013
Language:EN
[2013/12]
Search report(s)International search report - published on:AT20.09.2007
(Supplementary) European search report - dispatched on:EP16.07.2009
ClassificationIPC:A61K9/20, A61K31/4015
[2012/42]
CPC:
A61K9/209 (EP,US); A61K31/4015 (EP,US); A61P25/08 (EP)
Former IPC [2008/16]A61K9/52, A61K31/4015
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/16]
TitleGerman:KONTROLLIERT FREIGESETZTE, ORALE ZUSAMMENSETZUNG MIT LEVETIRACETAM[2008/16]
English:ORAL CONTROLLED RELEASE COMPOSITION CONTAINING LEVETIRACETAM[2008/16]
French:COMPOSITION A LIBERATION ORALE CONTROLEE CONTENANT DU LEVETIRACETAM[2008/16]
Entry into regional phase31.08.2007National basic fee paid 
31.08.2007Search fee paid 
31.08.2007Designation fee(s) paid 
31.08.2007Examination fee paid 
Examination procedure01.09.2006Request for preliminary examination filed
International Preliminary Examining Authority: AU
31.08.2007Amendment by applicant (claims and/or description)
31.08.2007Examination requested  [2008/16]
25.09.2009Despatch of a communication from the examining division (Time limit: M06)
22.03.2010Reply to a communication from the examining division
10.09.2012Date of oral proceedings
17.09.2012Minutes of oral proceedings despatched
23.10.2012Communication of intention to grant the patent
06.02.2013Fee for grant paid
06.02.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.09.2009
Opposition(s)02.01.2014No opposition filed within time limit [2014/09]
Fees paidRenewal fee
02.01.2008Renewal fee patent year 03
10.02.2009Renewal fee patent year 04
01.12.2009Renewal fee patent year 05
12.01.2011Renewal fee patent year 06
30.01.2012Renewal fee patent year 07
10.01.2013Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU22.02.2006
AT20.03.2013
BE20.03.2013
CY20.03.2013
CZ20.03.2013
DK20.03.2013
EE20.03.2013
FI20.03.2013
IT20.03.2013
LT20.03.2013
LV20.03.2013
MC20.03.2013
NL20.03.2013
PL20.03.2013
RO20.03.2013
SE20.03.2013
SI20.03.2013
SK20.03.2013
TR20.03.2013
BG20.06.2013
GR21.06.2013
IS20.07.2013
PT22.07.2013
[2016/33]
Former [2016/32]HU22.02.2006
AT20.03.2013
BE20.03.2013
CY20.03.2013
CZ20.03.2013
DK20.03.2013
EE20.03.2013
FI20.03.2013
IT20.03.2013
LT20.03.2013
LV20.03.2013
MC20.03.2013
NL20.03.2013
PL20.03.2013
RO20.03.2013
SE20.03.2013
SI20.03.2013
SK20.03.2013
BG20.06.2013
GR21.06.2013
IS20.07.2013
PT22.07.2013
Former [2014/44]AT20.03.2013
BE20.03.2013
CY20.03.2013
CZ20.03.2013
DK20.03.2013
EE20.03.2013
FI20.03.2013
IT20.03.2013
LT20.03.2013
LV20.03.2013
MC20.03.2013
NL20.03.2013
PL20.03.2013
RO20.03.2013
SE20.03.2013
SI20.03.2013
SK20.03.2013
BG20.06.2013
GR21.06.2013
IS20.07.2013
PT22.07.2013
Former [2014/11]AT20.03.2013
BE20.03.2013
CY20.03.2013
CZ20.03.2013
DK20.03.2013
EE20.03.2013
FI20.03.2013
IT20.03.2013
LT20.03.2013
LV20.03.2013
NL20.03.2013
PL20.03.2013
RO20.03.2013
SE20.03.2013
SI20.03.2013
SK20.03.2013
BG20.06.2013
GR21.06.2013
IS20.07.2013
PT22.07.2013
Former [2014/09]AT20.03.2013
BE20.03.2013
CY20.03.2013
CZ20.03.2013
DK20.03.2013
EE20.03.2013
FI20.03.2013
LT20.03.2013
LV20.03.2013
NL20.03.2013
PL20.03.2013
RO20.03.2013
SE20.03.2013
SI20.03.2013
SK20.03.2013
BG20.06.2013
GR21.06.2013
IS20.07.2013
PT22.07.2013
Former [2013/52]AT20.03.2013
BE20.03.2013
CY20.03.2013
CZ20.03.2013
EE20.03.2013
FI20.03.2013
LT20.03.2013
LV20.03.2013
NL20.03.2013
PL20.03.2013
RO20.03.2013
SE20.03.2013
SI20.03.2013
SK20.03.2013
BG20.06.2013
GR21.06.2013
IS20.07.2013
PT22.07.2013
Former [2013/50]AT20.03.2013
BE20.03.2013
CZ20.03.2013
EE20.03.2013
FI20.03.2013
LT20.03.2013
LV20.03.2013
NL20.03.2013
PL20.03.2013
RO20.03.2013
SE20.03.2013
SI20.03.2013
SK20.03.2013
BG20.06.2013
GR21.06.2013
IS20.07.2013
PT22.07.2013
Former [2013/49]AT20.03.2013
BE20.03.2013
CZ20.03.2013
EE20.03.2013
FI20.03.2013
LT20.03.2013
LV20.03.2013
NL20.03.2013
RO20.03.2013
SE20.03.2013
SI20.03.2013
SK20.03.2013
BG20.06.2013
GR21.06.2013
IS20.07.2013
PT22.07.2013
Former [2013/48]AT20.03.2013
BE20.03.2013
EE20.03.2013
FI20.03.2013
LT20.03.2013
LV20.03.2013
NL20.03.2013
SE20.03.2013
SI20.03.2013
BG20.06.2013
GR21.06.2013
IS20.07.2013
PT22.07.2013
Former [2013/47]BE20.03.2013
FI20.03.2013
LT20.03.2013
LV20.03.2013
SE20.03.2013
SI20.03.2013
BG20.06.2013
GR21.06.2013
PT22.07.2013
Former [2013/44]BE20.03.2013
FI20.03.2013
LT20.03.2013
LV20.03.2013
SE20.03.2013
SI20.03.2013
BG20.06.2013
GR21.06.2013
Former [2013/38]FI20.03.2013
LT20.03.2013
LV20.03.2013
SE20.03.2013
SI20.03.2013
BG20.06.2013
GR21.06.2013
Former [2013/37]FI20.03.2013
LT20.03.2013
SE20.03.2013
SI20.03.2013
BG20.06.2013
GR21.06.2013
Former [2013/34]LT20.03.2013
SE20.03.2013
BG20.06.2013
Former [2013/33]LT20.03.2013
Cited inInternational search[X]WO03101428  (DESITIN ARZNEIMITTEL GMBH [DE], et al);
 [X]US2004180088  (DUDHARA KAMLESH MOHANLAL [IN], et al);
 [X]EP1118321  (UCB SA [BE]);
 [XP]WO2006080029  (ALEMBIC LTD [IN], et al)
by applicantWO03101428
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.